Advancements in medical technologies and an increase in investments in R&D by manufacturers have resulted in the launch of various modern systems for genetic and molecular biology studies. Companies in the Europe enzymatic DNA synthesis market are involved in different product development activities. In November 2021, OriCiro Genomics Inc. launched the OriCiro Cell-Free Switching system. In June 2021, DNA Script commercially launched its SYNTAX platform with the first product—the SYNTAX System. This system is the first benchtop nucleic acid printer powered by enzymatic DNA synthesis (EDS) technology. The SYNTAX System is a fully integrated, automated printer that synthesizes 96 DNA oligos in parallel, each of length of up to 60 nucleotides, and delivers them ready for use in molecular biology and genomics workflows, eliminating the need for additional handling. In January 2021, Codex DNA, Inc. signed a strategic collaboration and licensing agreement with Pfizer to access and further develop the novel EDS technology of Codex DNA for its potential application in Pfizer’s mRNA-based vaccines and other biopharma products.
Such developments help end users meet the rising demand for technically advanced systems that can efficiently manage data and provide accurate results, thereby boosting the Europe enzymatic DNA synthesis market growth.
The Europe enzymatic DNA synthesis market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant market share in the enzymatic DNA synthesis market. The market is expected to witness significant growth during the forecast period due to factors such as the growing prevalence of genetic diseases and the favorable initiatives to detect diseases in the region.
Europe Enzymatic DNA Synthesis Market Segmentation
The Europe enzymatic DNA synthesis market is segmented into product type, application, technology, end user, and country.
Based on product type, the Europe enzymatic DNA synthesis market is segmented into custom DNA synthesis and DNA library synthesis. The DNA library synthesis segment held a larger share of the Europe enzymatic DNA synthesis market in 2022.
Based on application, the Europe enzymatic DNA synthesis market is segmented into synthetic biology, genetic engineering, therapeutic antibodies, vaccine design, and others. The synthetic biology segment held the largest share of the Europe enzymatic DNA synthesis market in 2022.
Based on technology, the Europe enzymatic DNA synthesis market is segmented into SOLA, CRISPR, PCR, and others. The PCR segment held the largest share of the Europe enzymatic DNA synthesis market in 2022.
Based on end user, the Europe enzymatic DNA synthesis market is segmented into academic & research institutes, biotech & pharmaceutical companies, diagnostic laboratories, and others. The biotech and pharmaceutical companies segment held the largest share of the Europe enzymatic DNA synthesis market in 2022
Based on country, the Europe enzymatic DNA synthesis market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The Germany dominated the share of the Europe enzymatic DNA synthesis market in 2022.
Camena Bio; DNA Script; Evonetix; GenScript Biotech Corporation; Synbio Technologies; Telesis Bio Inc; Touchlight; and Twist Bioscience are the leading companies operating in the Europe enzymatic DNA synthesis market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 78.55 Million |
| Market Size by 2028 | US$ 727.79 Million |
| CAGR (2022 - 2028) | 44.9% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Enzymatic DNA Synthesis Market is valued at US$ 78.55 Million in 2022, it is projected to reach US$ 727.79 Million by 2028.
As per our report Europe Enzymatic DNA Synthesis Market, the market size is valued at US$ 78.55 Million in 2022, projecting it to reach US$ 727.79 Million by 2028. This translates to a CAGR of approximately 44.9% during the forecast period.
The Europe Enzymatic DNA Synthesis Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Enzymatic DNA Synthesis Market report:
The Europe Enzymatic DNA Synthesis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Enzymatic DNA Synthesis Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Enzymatic DNA Synthesis Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Enzymatic DNA Synthesis Market
